title: One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians.
abstract: BACKGROUND
  Pneumococcal conjugate vaccine (PCV7) was recommended by June 2000 for administration to all US children </=23 months old and to children at high risk for pneumococcal disease 24 to 59 months old. We sought to identify physician characteristics associated with adoption of the recommendation within 1 year.
  
  
  METHODS
  We conducted a cross-sectional mail survey from April to July, 2001, of 788 family physicians (FP) and 833 pediatricians (PD) in 24 states. We measured whether physicians had adopted PCV7 recommendations, their expectations of the effectiveness of PCV7, the number of vaccine injections they would consider administering at 1 visit, and barriers to administering multiple injections.
  
  
  RESULTS
  Response rate was 60%. Overall, 87% of physicians had adopted PCV7 recommendations (68% FP; 99% PD; P <.001). FP adopters are significantly more likely than nonadopters to believe PCV7 will be effective in preventing pneumococcal sepsis and meningitis, as well as >25% of cases of otitis media. In multivariable logistic regression analyses of adoption of PCV7, FP who have higher proportions of African American patients and patients on Medicaid, see greater numbers of newborns, work in practices of >/=4 physicians, and are willing to consider administering at least 4 vaccine injections at 1 visit are significantly more likely to have adopted PCV7. Concerns about vaccine cost and reimbursement were the most commonly cited factors in physicians' decisions not to adopt PCV7 recommendations.
  
  
  CONCLUSIONS
  One year after PCV7 was recommended, nearly all pediatricians and a majority of family physicians had incorporated this vaccine into their practices. Barriers to higher rates of uptake-especially among family physicians-must be addressed to achieve immunization goals with this new vaccine.
authors.affiliation: Child Health Evaluation and Research Unit, Division of General Pediatrics, Ann Arbor, MI 48109, USA.
authors.forename: Matthew M
authors.initials: MM
authors.lastname: Davis
authors.forename: Serigne M
authors.initials: SM
authors.lastname: Ndiaye
authors.forename: Gary L
authors.initials: GL
authors.lastname: Freed
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Clark
mesh_terms: D001291:Attitude of Health Personnel; D044383:Black People / Q000706:statistics & numerical data; D003430:Cross-Sectional Studies; D005260:Female; D006123:Group Practice / Q000458:organization & administration; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008484:Medicaid / Q000706:statistics & numerical data; D015999:Multivariate Analysis; D010372:Pediatrics / Q000706:statistics & numerical data*; D010821:Physicians, Family / Q000706:statistics & numerical data*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage* / Q000191:economics; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D012051:Reimbursement Mechanisms; D011795:Surveys and Questionnaires; D014481:United States; D018074:Vaccines, Conjugate / Q000008:administration & dosage / Q000191:economics; D001741:Black or African American
chemical_list: D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate